Abstract:Introduction: Patients who are considered high-risk for choledocholithiasis after biochemical testing and abdominal ultrasound (AUS) are recommended to undergo endoscopic retrograde cholangiopancreatography (ERCP) with others to receive less invasive tests. The aim of the study is to determine whether high-risk patients by ASGE guidelines or other factors can accurately identify those with choledocholithiasis.Table 1: Diagnostic Performance of ASGE High-Risk Group and Other Test Characteristics in Patients with Suspected Choledocholithiasis ( N =2,726)Methods: Consecutive patients hospitalized (1/2011-12/2013) with suspected choledocholithiasis who received biochemical testing, AUS and definitive testing for choledocholithiasis (magnetic resonance cholangiopancreatography (MRCP), endoscopic ultrasound (EUS), ERCP, interventional radiology procedure and/or intraoperative cholangiogram (IOC)) at Sir Run Run Shaw Hospital were retrospectively identified. Patients with choledocholithiasis on AUS, bilirubin >4mg/dL, bilirubin >1.8mg/dL + dilated common bile duct (CBD) (>8mm and >6mm with or without prior cholecystectomy) and/or suspected cholangitis (presenting fever and/or leukocytosis) were considered high-risk per ASGE guidelines. Final diagnosis was based on choledocholithiasis identified on definitive testing. Results: Mean age of 2,726 patients with suspected choledocholithiasis was 55+15 yrs, 1,179 (43%) were male and 216 (8%) had prior cholecystectomy. On definitive testing (MRCP in 2,441 (90%), EUS in 69 (3%), interventional radiology procedure in 2, ERCP in 643 (23%), IOC in 189 (7%)), 1,076 (39%) patients had choledocholithiasis. A higher proportion of patients meeting ASGE high-risk criteria compared to other groups (770/1,271 (61%) vs. 306/1,455 (21%); OR=5.8, 95%CI 4.9-6.8) had confirmed choledocholithiasis. Diagnostic performance of test characteristics is shown (Table). On multivariate analysis, choledocholithiasis on AUS (AOR=17.4, 95%CI 12.6-23.9), bilirubin >4mg/dL (AOR=3.0, 95%CI 2.2-4.1) and bilirubin 1.8-4mg/dL (AOR=1.8, 95%CI 1.4-2.4) compared to < 1.8mg/dL and CBD dilation (AOR=1.8, 95%CI 1.5-2.2) increased the likelihood of choledocholithiasis. Conclusion: In patients with suspected choledocholithiasis, the specificity of high-risk group categorized by ASGE guidelines was suboptimal. Combination of factors that include choledocholithiasis on AUS and bilirubin >4mg/dL with or without CBD dilation had high specificities of >90% and moderate to high positive likelihood ratios. A revised algorithm with more stringent criteria may improve patient selection and reduce the risk of diagnostic ERCP.

Risk factors for the recurrence of stones after endoscopic minimally invasive cholecystolithotomy in China: a meta-analysis

The comparative analysis between two methods for minimally invasive surgery in the treatment of cholecystolithiasis and choledocholithiasis

Suboptimal Specificity of Asge High-Risk Group in Evaluation of Patients with Suspected Choledocholithiasis

Intraoperative ERCP and endoscopic sphincterotomy combined with laparoscopic cholecystectomy for treatment of cholelithiasis with choledocholithiasis

The multi-center investigation on operative complications for patients with cholelithiasis

The Impact of Metabolic Factors and Lipid-Lowering Drugs on Common Bile Duct Stone Recurrence after Endoscopic Sphincterotomy with Following Cholecystectomy

Establishment and evaluation of prediction model of recurrence after laparoscopic choledocholithotomy

Risk factors and management of primary choledocholithiasis: a systematic review

Risk factors for recurrence of common bile duct stones after surgical treatment and effect of ursodeoxycholic acid intervention

Risk Factors for Retained Common Bile Duct Stones of Laparoscopic Cholecystectomy

A New Operation for Gallstones: Choledochoscopic Gallbladder-Preserving Cholecystolithotomy, a Retrospective Study of 3,511 Cases.

Microbiologic risk factors of recurrent choledocholithiasis post-endoscopic sphincterotomy.

Clinical analysis of endoscopic sphincterotomy for choledocholithiasis

Long-Term Prognosis of Cholecystocholedocholithiasis in Chinese Population

Recurrence of common bile duct stones after choledocholithotomy in elderly patients: risk factor analysis and clinical prediction model development

A preliminary study of endoscopic trans-gastric gallbladder-preserving cholecystolithotomy for cholecystolithiasis ( with video)

Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China

Risk Factors for Recurrent Common Bile Duct Stones After Endoscopic Retrograde Cholangiopancreatography

Clinical predictors of recurrent cholecystitis in non-operative management: A systematic review & meta-analysis

Identification of risk factors for obstructive cholecystitis following placement of biliary stent in unresectable malignant biliary obstruction: a 5-year retrospective analysis in single center

Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies